Bayer chooses Fluor and GE Healthcare for new cell culture technology

摘要

US Bayer will invest US$150 million in its Berkeley pharmaceutical development and manufacturing campus in California, US. The project will see the construction of a Cell Culture Technology Center that will be used to accelerate the development of biological therapies. Once complete, the facility will support Bayer's growing portfolio in biologies to serve multiple patient populations."This investment allows Bayer to expand our biologies development and launch capabilities, as we advance our R&D programmes internally and through strategic collaborations," said Wolfram Carius, Executive VP and Head of Product Supply.